ArticleEJHaem2025

Venetoclax Consolidation After Bruton Tyrosine Kinase Inhibitor Treatment for Patients With Chronic Lymphocytic Leukemia.

Benjamin Heyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.